Novartis has received approval from the U.S. Food and Drug Administration for Itvisma, a treatment for spinal muscular atrophy. Dr. John Day is professor of neurology and pediatrics, director of the ...

Novartis has received an FDA approval for Itvisma, a new version of the company’s gene therapy Zolgensma, to treat older patients with spinal muscular atrophy (SMA). The approval comes more than six ...

FDA approved Itvisma, a gene therapy for SMA patients aged 2 and older. Itvisma delivers a healthy SMN1 gene via spinal injection in a one-time treatment. This expands gene therapy access to older ...

NEW YORK, NEW YORK - FEBRUARY 21: (L-R) Jimin, Jungkook, RM, J-Hope, V, Jin, and SUGA of the K-pop boy band BTS visit the "Today" Show at Rockefeller Plaza on February 21, 2020 in New York City.